indiaUpdated: Nov 19, 2020, 07:56 ISTThe Indian Council of Medical Research (ICMR) on Wednesday issued a new advisory on convalescent plasma therapy (CPT) that lays down specific criteria for its use to stop indiscriminate use in the treatment of coronavirus disease (Covid-19). It is speculated that convalescent plasma having low concentration of specific antibody against SARS-CoV-2 may be less beneficial for treating Covid-19 patients as compared to plasma with high concentration of such antibodies,” said the ICMR advisory. “This advisory therefore embraces the principle that a potential donor for convalescent plasma should have sufficient concentration of antibody working against Covid-19... It also highlights that presence of antibody against Covid-19 in a potential recipient makes transfusing convalescent plasma a futile intervention,” it further said. An informed consent has to be taken from the recipient or their family before transfusing convalescent plasma.

Source: Hindustan Times November 19, 2020 02:29 UTC